Post-market surveillanceAndrogen Modulator
Compound 61689
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061689
Risk Class
MODERATE
Last Audit
Jun 13, 2108
Research Abstract
Androgen Modulator candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61689 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in post-market surveillance with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061689 with updates logged 2108-06-13.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61689Androgen Modulator Program 61689
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061689
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61689